Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB4 in Healthy Male Subjects
Clinical trial NCT01865552 · COMPLETED
Trial details
- NCT number
- NCT01865552
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2013-08-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.